Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Omnicell Inc (NQ: OMCL )

42.12 -0.83 (-1.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 300,545
Open 42.46
Bid (Size) 41.83 (1)
Ask (Size) 42.50 (2)
Prev. Close 42.95
Today's Range 41.70 - 42.52
52wk Range 25.12 - 45.85
Shares Outstanding 43,474,327
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Analyst Verdict: Omnicell In The Eyes Of 6 Experts
Via Benzinga
Omnicell to Release Third Quarter 2024 Financial Results on October 30, 2024
From Omnicell, Inc.
Via Business Wire

Performance

YTD
+12.83%
+12.83%
1 Month
-2.64%
-2.64%
3 Month
+57.34%
+57.34%
6 Month
+54.17%
+54.17%
1 Year
-5.79%
-5.79%

More News

Read More
Omnicell Appoints Nnamdi Njoku as Executive Vice President and Chief Operating Officer
From Omnicell, Inc.
Via Business Wire
The Analyst Landscape: 5 Takes On Omnicell
Via Benzinga
Omnicell Announces Central Med Automation Service
From Omnicell, Inc.
Via Business Wire
Earnings Scheduled For February 8, 2024
Via Benzinga
Omnicell to Present at the 2024 Wells Fargo Healthcare Conference
From Omnicell, Inc.
Via Business Wire
Crude Oil Moves Lower; Moderna Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Dow Drops Over 500 Points As Data Rolls In
Via Talk Markets
Topics Stocks
Exposures US Equities
Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July
Via Benzinga
Topics Stocks
Exposures US Equities
Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
EnlivenHealth® and Good Neighbor Pharmacy® Seek to Empower Independent Pharmacies with New Clinical Scope of Practice and Reimbursement Solution
From Omnicell, Inc.
Via Business Wire
Omnicell Announces Second Quarter 2024 Results
From Omnicell, Inc.
Via Business Wire
3 Russell 2000 Stocks to Buy at a 52-week Low in July
Via InvestorPlace
Topics Stocks
Exposures US Equities
Omnicell to Release Second Quarter 2024 Financial Results on August 1, 2024
From Omnicell, Inc.
Via Business Wire
Omnicell Supports Global Charity Mercy Ships with Pharmacy Technology Donation
From Omnicell, Inc.
Via Business Wire
Omnicell to Present at the BofA Securities 2024 Health Care Conference
From Omnicell, Inc.
Via Business Wire
OMCL Stock Earnings: Omnicell Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Omnicell Announces First Quarter 2024 Results
From Omnicell, Inc.
Via Business Wire
Omnicell Announces XT Amplify
From Omnicell, Inc.
Via Business Wire
Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
From Omnicell, Inc.
Via Business Wire
3 Robotics Stocks That Could Soar as the Technology Advances
Via InvestorPlace
Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
From Omnicell, Inc.
Via Business Wire
Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results
From Omnicell, Inc.
Via Business Wire
Omnicell to Release Fourth Quarter and Full Year 2023 Financial Results on February 8, 2024
From Omnicell, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.